Background: Fluoroquinolones have been associated with increased risk of tendinopathy and Achilles tendon rupture (ATR), especially in patients over 60 years of age.
Methods: A retrospective study was carried out including patients over 60 years of age with ATR attended in our centre over the period 2000-2017.
Results: We identified 44 patients with RTA, of whom 18% (8/44) had been previously treated with fluoroquinolones, with a mean age at diagnosis of ATR of 77.37 years and concomitant corticotherapy in 4 of them. In 7patients, the rupture was spontaneous and all required surgical management. A significantly higher frequency of smoking, concomitant corticotherapy and spontaneous ruptures were found in the group treated with fluoroquinolones.
Conclusions: ATR is an adverse event that can occur in patients over 60 years of age treated with fluoroquinolones, so an adequate risk-benefit assessment should be carried out in this population, especially in the presence of associated risk factors.
Keywords: Achilles tendon rupture; Ciprofloxacin; Ciprofloxacino; Fluoroquinolonas; Fluoroquinolones; Levofloxacin; Levofloxacino; Rotura del tendón de Aquiles; Tendinopathy; Tendinopatía.
Copyright © 2019 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.